Fresenius Medical Care Corp (NYSE:FMS) ranks in the top 10% of its industry group, Health Care Providers & Services, and in the top decile of sector group, Health Care, with a market value of $30.0 billion. From an investment attractiveness prospective, FMS is ranked in the top quartile of the sector with a ranking of 169 among the 782 companies in the sector; the stock's Portfolio Grader ranking places it 20 among the 82 companies in this industry group, giving it a well above-average position and number 1,197 in the 5000 company Portfolio Grader company universe.
The current recommendation of Strong Buy for Gyrodyne Co of America (NASDAQ:GYRO) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.